N-((6-Chloropyridin-3-yl)methyl)ethanamine, 95.0%, 100mg

1-((4-Nitrophenyl)sulfonyl)piperidine, 95.0%, 10g

9-Methyladenine, 95.0%, 1g

Dichloromethane, PEPTIPURE®, min. 99.9%, for peptide synthesis, 2.5 l, glass packaging

2-Hexenal diethyl acetal, predominantly trans, 5g

1-Pyrimidin-2-yl-piperidine-4-carboxylic acid ethyl ester, 95.0%, 5g

5-Bromo-1,3,4-thiadiazole-2-carboxylic acid, 95%, 500mg

3,5-Bis(benzyloxy)benzoic acid, 95.0%, 500g

1-Methyl-2-(prop-2-yn-1-yloxy)benzene, 95%, 5g

LOUREIRIN A, 95%, 250mg

(2-(DIETHYLAMINO)PYRIMIDIN-5-YL)BORONIC ACID, 95.0%, 250mg

2-amino-4-fluoro-5-(4-methyl-1,4-diazepan-1-yl)benzoic acid, 97%, 500mg

tert-Butyl (4R,6R)-2-[6-[2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate>98.0%(HPLC)(N)5g